Previous Close | 1.6450 |
Open | 1.6450 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.6450 - 1.6450 |
52 Week Range | 1.6450 - 6.6000 |
Volume | |
Avg. Volume | 29,855 |
Market Cap | 6.848B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 14.95 |
EPS (TTM) | 0.1100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to announce its audited annual results for the year ended December 31, 2023 ("Reporting Period").
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced it has been recognized for leadership in corporate transparency and performance on water security by the environmental non-profit CDP, securing a place on its annual 'A List'.